Drug Store News - OTC meds add some flavor
[ILLUSTRATION OMITTED]
Following in the footsteps of McNeil Consumer, Boehringer Ingelheim recently made a big splash in the digestives aisle with a little pizzazz flavored into its H2-blocker, Zantac 150. The company launched Zantac 150 Cool Mint tablets, helping to continue the company’s growth curve of 14.8 percent to $71.8 million for the 52 weeks ended Sept.9, according to Information Resources Inc., across food, drug and mass (minus Wal-Mart).
Related Results
The Real Value in Setting the Right Price
Footsie gets high on heady mix of drugs and oils
Arthritis drug combo can mask symptoms
Warner-Lambert, Burroughs Wellcome agree to joint venture.
Advertising next week … (Brandwatch).(Brief Article)
The move has helped make Zantac the No. 1 H2-blocker in mass–surpassing Johnson & Johnson’s Pepcid AC ($63.7 million, down 17 percent) and Pepcid Complete ($56.5 million, up 11 percent). McNeil first test-marketed coating a non-chewable tablet with flavor when launching Tylenol Sinus Severe Congestion with Cool Burst in September 2003, followed by Adult Extra Strength Tylenol Cool caplets in April 2004.
COPYRIGHT 2007 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
